Maximilian Webendörfer Linda Reinhard Rolf A K Stahl Thorsten Wiech Hans-Willi Mittrücker Sigrid Harendza Elion Hoxha
10.3389/fimmu.2020.586012
Front Immunol
2021 Feb 8;11:586012.
b cell depletion therapy cd20+ t cells minimal change disease nephrotic syndrome rituximab
CC BY
https://pubmed.ncbi.nlm.nih.gov/33628202/
Immunologic Factors / therapeutic use Nephrosis, Lipoid / drug therapy Nephrosis, Lipoid / immunology Rituximab / therapeutic use
Immunologic Factors / therapeutic use Nephrosis, Lipoid / drug therapy Nephrosis, Lipoid / immunology Rituximab / therapeutic use Case Reports Research Support, Non-U.S. Gov't Aged B-Lymphocytes / immunology Humans Male Nephrosis, Lipoid / complications Proteinuria / etiology Remission Induction T-Lymphocytes / immunology Immunologic Factors Rituximab
PMC7897659
33628202
Rituximab Induces Complete Remission of Proteinuria in a Patient With Minimal Change Disease and No Detectable B Cells
2021